Cytokinetics
CYTK
CYTK
142 hedge funds and large institutions have $584M invested in Cytokinetics in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
4% less funds holding
Funds holding: 148 → 142 (-6)
13% less call options, than puts
Call options by funds: $2.59M | Put options by funds: $2.98M
Holders
142
Holding in Top 10
3
Calls
$2.59M
Puts
$2.98M
Top Buyers
| 1 | +$32.3M | |
| 2 | +$27.5M | |
| 3 | +$11.6M | |
| 4 |
Jennison Associates
New York
|
+$6.47M |
| 5 |
Millennium Management
New York
|
+$6.14M |
Top Sellers
| 1 | -$8.85M | |
| 2 | -$7.4M | |
| 3 | -$2.4M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$2.14M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.85M |